Cannabinoid-based vaping products and supplement formulations reported by consumers to precipitate adverse effects

• NCJ Number: 304539
• Journal: Drug Testing and Analysis Volume: Online Issue: Special Issue Dated: March 2022
• Author(s): Alaina K. Holt; Kimberly N. Karin; Shelle N. Butler; Amanda R. Ferreira; Alex J. Krotulski; Justin L. Poklis; Michelle R. Peace
• Date Published: March 2022
• Length: 9 pages
• Grant Number(s): 2014-R2-CX-K010; 2016-DN-BX-0150; 2018-75-CX-0036; 2019-MU-MU-0007
• Agencies: NIJ-Sponsored
• Publication Type: Research (Applied/Empirical)
• Award: Characterization and Abuse of Electronic Cigarettes: The Efficacy of a Personal Vaporizer as an Illicit Drug Delivery System; Chasing the Electronic Cigarette Dragon - Characterizing the Evolution and Impact of Design and Content; Through the E-Cigarette Looking Glass: The Impact of Vaping Ethanol on DUI Investigations; Through the Looking Glass Part II: Abuse of the Evolving Electronic Cigarette and the Impact of Vaping Ethanol in the Evaluation of Impairment

Annotation

Cannabinoid-based products submitted by consumers experiencing adverse effects were analyzed to identify and quantitate ingredients.

Abstract

Product testing identified several synthetic cannabinoids and products with inaccurate or incomplete labeling. (Publisher Abstract)